Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Development of tacrolimus eye drops voluntarily suspended

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Development of tacrolimus eye drops voluntarily suspended. React. Wkly. 1058, 2 (2005). https://doi.org/10.2165/00128415-200510580-00001

    Download citation

    Keywords

    • Cancer Risk
    • Tacrolimus
    • Healthcare Professional
    • Patient Safety
    • Editorial Comment